ARTICLES BY BOB MARSHALL
A New “Strategic Engine” For Developing Drugs, Diagnostics, & Devices
LifeX currently is home to 20 companies that are developing new drugs, diagnostics, devices, and population health solutions for very large unmet health needs. But its CEO says it’s not an incubator or a fund.
4 Keys To Choosing The Right Regulatory Consultant
I spent the first two decades of my medical device career with startups and larger OEMs, working with or hiring consultants, as needed, for support. I then became a consultant for seven years, and I saw outsourced support from the other side. Now, I want to share some perspective on outsourced support. These important relationships can make or break your business.
Inside The Mind Of Life Science Innovator Mir Imran
After discovering that there have been up to 200 unsuccessful attempts at delivering biologic drugs orally, serial medical-device inventor and entrepreneur Mir Imran decided to tackle the problem.
7 Medical Device Leaders Talk About What’s Next For Their Industry
Seven industry experts answer questions related to the med device funding climate, which device segment will be getting all of the attention in 2018, and upcoming M&A activity related to med devices.
When Regulatory Goes Wrong
In spite of my preference for “happily ever-after” as detailed in a previous article, sometimes things do not go well for medical device companies as it pertains to regulatory affairs.
3 Medtech Regulatory Successes (That Started As Failures)
These tales prove that it's possible to snatch victory from the hands of regulatory defeat when responding to adversity with open-minded persistence.